Lindis Blood Care Announces Successful Financing for CATUVAB®
Deal News | Dec 13, 2024 | High-Tech Gruenderfonds Manage
Lindis Blood Care, a German company based in Hennigsdorf, has announced a significant milestone in securing financing for its novel medical device, CATUVAB®, which is designed to effectively and safely remove tumor cells from autologous blood. This medical advancement marks an innovative approach toward cancer treatment. The first closing of this funding round was successfully supported by Brandenburg Kapital, High-Tech Gründerfonds, along with existing and new private investors. With the financing in place, Lindis Blood Care aims to use the funds to prepare for the upcoming approval and product launch of CATUVAB® in Europe. The second closing is anticipated by the end of the first quarter of 2025. This financing marks a pivotal step in bringing CATUVAB® to market, promising a cost-effective and reliable solution for tumor cell removal, holding great potential for improving patient outcomes.
Sectors
- Healthcare
- Medical Devices
Geography
- Germany – Lindis Blood Care is based in Hennigsdorf, Germany, and the upcoming product launch is planned for the European market.
- Europe – The product launch of CATUVAB® is targeted for the European market, necessitating regulatory approval.
Industry
- Healthcare – The healthcare industry is relevant as the article discusses Lindis Blood Care's medical device aimed at improving cancer treatment.
- Medical Devices – The article focuses on CATUVAB®, a medical device for tumor cell removal, which is a part of the medical devices sector.
Financials
- Not Specified – Exact figures of the financing round were not disclosed in the article.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Lindis Blood Care | Target company | Company | A medical company developing CATUVAB®, a device for removing tumor cells from blood. |
| High-Tech Gründerfonds | Investor | Company | A private equity firm that supports Lindis Blood Care's funding round for the CATUVAB® device. |
| Brandenburg Kapital | Investor | Company | An investment firm involved in the funding round for Lindis Blood Care's medical device. |